Work

A Phase I Dose Escalation Study of the mTOR Inhibitor Sirolimus and MEC Chemotherapy Targeting Signal Transduction in Leukemic Stem Cells for Acute Myeloid Leukemia.

Year: 2006

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v108.11.161.161

Authors: Selina Luger, Alexander Perl, Allison Kemner, Edward A. Stadtmauer, David Porter, Stephen J. Schuster, Stephen C. Goldstein, Donald E. Tsai, S. Nasta, A. Loren, Jamil K. Dierov, D. Vogl, C. Andreadis, Stephen G. Emerson, Martin Carroll

Institutions: Abramson Cancer Center, University of Pennsylvania

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2553566409

FWCI: 1.261

Cites:

Cited by: 9

Related to: 10